We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

83 hedge funds and large institutions have $70.2M invested in ENZON PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 83 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

90% less call options, than puts

Call options by funds: $2K | Put options by funds: $20K

Holders
83
Holders Change
+83
Holders Change %
–
% of All Funds
2.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
83
Increased
–
Reduced
–
Closed
–
Calls
$2K
Puts
$20K
Net Calls
-$18K
Net Calls Change
-$18K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ENZN Hedge Fund Activity: Q2 2013 in Review

83 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2013, worth a combined $70.2M.

Buyers outnumbered sellers: 83 funds opened new ENZN positions and 0 closed out — a net gain of 83 holders — while 0 added to existing stakes and 0 trimmed.

  • 83 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $70.2M of ENZON PHARMACEUTICALS INC stock for Q2 2013.
  • 83 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +83 holders.

Based on aggregated 13F filings for Q2 2013.